TRex Bio, Inc. TRXB
Set alert
13.74 USD +0.22 +1.63%
At close · Oct 30
13.74 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
13.10 Day range 13.84
13.50 52-week range 15.50
- YTD
- -1.86%
- 1 year
- -1.86%
- Open
- 13.45
- Prev close
- 13.52
- Mkt cap
- 377.10M
- Vol
- 39.18K
- Avg vol
- 184.23K
- EPS
- -2.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.10
- High
- 13.84
News
-
2 weeks ago benzinga.com
Eli Lilly Takes 19.9% Stake In TRex Bio With 5.48M Shares, Investing $12.3M In IPO
The Reporting Person beneficially owns an aggregate of 5,480,872 shares of Common Stock of the Issuer, consisting of (a) 2,510,411 shares of Common Stock that were issued to the Reporting Person upon…
2 weeks ago globenewswire.com
TRexBio Announces Closing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. (“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and…
3 weeks ago globenewswire.com
TRexBio Announces Pricing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. (“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and…